Clinical Trial

The Bipolar Illness Onset Study (the BIO Study)

Study acronym: BIO
Active, Not Recruiting
View on ClinicalTrials.gov →
Summary
This longitudinal study aims to identify 1) a composite blood-based biomarker, 2) a composite electronic Smartphone-based biomarker and 3) a neurocognitive signature for bipolar disorder
Protocol Amendment History 4 amendments
This ClinicalTrials.gov record has been amended 4 times since 2016-09-01; most recent amendment 2023-10-17.
Status change: Recruiting → Active, Not Recruiting 2023-10-17
Trial Details
NCT Number NCT02888262
Lead Sponsor Mental Health Centre Copenhagen, Bispebjerg and Frederiksberg Hospital
Collaborators: University of Copenhagen
Conditions Bipolar Disorder
Enrollment 700 participants
Start Date 2016-01
Primary Completion 2026-12 (estimated)
Study Completion 2026-12 (estimated)
Updated on ClinicalTrials.gov 2023-10-19